fashion -WSS

fashion

author：fashion 2025-08-26 23:45:47 - browse：7

Rod Nathan, Ali Urman, and Patrick Nosker on the 2024 Breakthrough Summit East stage. — From left, Rod Nathan, portfolio manager and partner of J. Goldman & Co.; ARK Invest senior analyst Ali Urman; and Patrick Nosker, director of research and partner at Affinity Asset Advisors, discuss biotech investment opportunities at the 2024 STAT Breakthrough Summit East. STAT

Following a blockbuster year of dealmaking and a recent uptick in biotech stocks, top investors see more good news on the horizon.

Driving the momentum? Economics 101.

Biotechs rely on borrowing capital, which is a more tenuous task when interest rates are high. But interest rates have most likely peaked, with Federal Reserve officials signaling earlier this week they expected to make three cuts this year. For public biotechnology startups that have been battered by the market in recent years, this is a very good thing, Rod Nathan, portfolio manager and partner of J. Goldman & Co., said on a panel at STAT’s Breakthrough Summit East in New York on Thursday.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： Listen: More tumult at BIO & coercive care for sickle cell patients

hotspot

WSS

Who is Jack Smith, the special counsel overseeing the DOJ's Trump probes?

Judge partially blocks Texas abortion ban for medical emergencies, fatal diagnoses

Judge partially blocks Texas abortion ban for medical emergencies, fatal diagnoses

Study finds gene variants tied to breast cancer risk in Black women

Listen: Biotech layoffs, eye drug drama, & gene therapy milestones

CDC recommends RSV monoclonal antibody for infants

entertainment

fashion

hotspot

State Dept. review finds Biden bears some blame for Afghanistan failures

H5N1 virus can be tracked in retail milk, scientists say

Supreme Court strikes down use of affirmative action

Judge partially blocks Texas abortion ban for medical emergencies, fatal diagnoses

George Santos makes 1st court appearance after pleading not guilty to 13 counts

The Readout: Biogen, Guardant, AstraZeneca, H5N1 vaccine

Sports medicine is finally prioritizing gender equality

Group behind ProMed defends move to subscription

Guidelines to prevent youth baseball injuries need more muscle

Biogen joins immunology wave with $1.15 billion acquisition of HI

leisure time

Biotech startup Celsius cuts 75% of staff ahead of first trial start

Study links childhood stress with decline in older age

The a glaring gap in research on serious mental illness and primary care

Cytokinetics sells Royalty Pharma a share of its heart drug for up to $575M

Cytokinetics CEO Robert Blum is on my Worst CEO shortlist again

Questions and answers about ramping up H5N1 bird flu vaccine

focus

Wikipedia

hotspot

leisure time